G6PD and cancer: In vivo, knockdown or overexpression of G6PD has previously been shown to affect tumor growth in subcutaneous xenograft models in a small number of other cancer systems (17, 28, 52, 53), highlighting the importance of this pathway in cancer cell survival, but not incorporating key components of the tumor microenvironment.